By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ab Initio Biotherapeutics 

280 Utah Avenue

South San Francisco  California  94080  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Ab Initio's mission and passion is to create innovative drugs for challenging biological problems.

Discovery Platform

At Ab Initio, we are using a directed evolution display-based discovery platform in combination with a first-principles approach to create the next generation of protein therapeutics. Our proprietary display technologies, antibody libraries, and techniques in protein receptor biochemistry enable the development of agents with highly specialized and precisely tuned biological activities.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Kenneth Lin, MD

Head of Biology: Roy Maute, PhD

Head of Biochemistry: John Burg, PhD


Key Statistics


Email: info@aibiothera.com
Ownership: Private

Web Site: Ab Initio
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->